1. Home
  2. BHC

as of 02-18-2026 3:47pm EST

$6.21
+$0.02
+0.32%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Founded: N/A Country:
US
Employees: N/A City: QUEBEC
Market Cap: 2.5B IPO Year: 1996
Target Price: $8.67 AVG Volume (30 days): 2.2M
Analyst Decision: Hold Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: quarterly
EPS: 0.42 EPS Growth: 423.08
52 Week Low/High: $4.28 - $8.69 Next Earning Date: 05-18-2026
Revenue: $8,724,000,000 Revenue Growth: -9.82%
Revenue Growth (this year): 6.67% Revenue Growth (next year): 4.23%
P/E Ratio: 8.66 Index: N/A
Free Cash Flow: 1.0B FCF Growth: -20.40%

AI-Powered BHC Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 76.40%
76.40%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Bausch Health Companies Inc. News

BHC Breaking Stock News: Dive into BHC Ticker-Specific Updates for Smart Investing

All BHC News

Share on Social Networks: